ArticleFrontiers in oncology2026
Case Report: A rare case of external iliac artery rupture and sigmoid fistula following multimodal treatment for cervical cancer.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a 58-year-old woman with cervical squamous cell carcinoma who developed an early-onset left external iliac artery rupture followed by a sigmoid fistula after multimodal treatment. Notably, key baseline tumor parameters-including maximal tumor diameter and stromal invasion depth-were not documented preoperatively because PET-CT was not performed and the original MRI/CT datasets from the outside hospital were unavailable. This incomplete staging likely contributed to underestimation of disease extent and to selection of a non-guideline-concordant primary radical hysterectomy, although postoperative pathology ultimately confirmed FIGO 2018 stage IIIC2 disease with extensive nodal metastases. The patient subsequently received adjuvant pelvic external-beam radiotherapy and vaginal cuff high-dose-rate brachytherapy. One month after completing radiotherapy, she presented with acute hematochezia and hemorrhagic shock. Angiography revealed active extravasation from the left external iliac artery adjacent to a postoperative lymphocele, and a covered stent was deployed with temporary hemostasis. Despite intensive antimicrobial and supportive therapy, she later developed a sigmoid fistula, pelvic abscess, recurrent bleeding, and persistent sepsis, culminating in fatal deterioration. The arterial rupture was considered to be multifactorial, with potential contributions from extensive lymphadenectomy, lymphocele formation, infection, and radiation-related tissue fragility. This case underscores the critical importance of comprehensive preoperative assessment and guideline-based primary treatment selection in cervical cancer, as inappropriate initial management may predispose patients to severe lymphatic, infectious, and vascular complications. Early multidisciplinary surveillance and timely intervention may be essential to prevent catastrophic outcomes. In gynecologic oncology, the combination of early-onset iliac arterial rupture and subsequent sigmoid fistula shortly after postoperative radiotherapy remains exceedingly rare, and to our knowledge has not been previously reported in a patient with unrecognized FIGO IIIC2 disease at initial treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.